Clinical Trial Update: Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study of JANX008 in advanced or metastatic solid tumors is currently recruiting, evaluating multiple indications including Non-Small Cell Lung Cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma
• Renal Cell Carcinoma
• Small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck
• Triple-negative Breast Cancer

Drugs mentioned

• JANX008

Snippet

Sponsor: Janux Therapeutics | Conditions: Non-Small Cell Lung Cancer, Renal Cell Carcinoma | Phase 1 | Status: RECRUITING